Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 Mar;59(3):161–163. doi: 10.1136/ard.59.3.161

Systemic vasculitis: epidemiology, classification and environmental factors

D SCOTT 1, R WATTS 1
PMCID: PMC1753099  PMID: 10700420

Full Text

The Full Text of this article is available as a PDF (85.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., Romain P. L. Mixed cryoglobulinemia secondary to hepatitis C virus infection. Rheum Dis Clin North Am. 1996 Feb;22(1):1–21. doi: 10.1016/s0889-857x(05)70259-3. [DOI] [PubMed] [Google Scholar]
  2. Andrews M., Edmunds M., Campbell A., Walls J., Feehally J. Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond. 1990 Oct;24(4):284–288. [PMC free article] [PubMed] [Google Scholar]
  3. Bae S. C., Fraser P., Liang M. H. The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the "prevalence gradient hypothesis". Arthritis Rheum. 1998 Dec;41(12):2091–2099. doi: 10.1002/1529-0131(199812)41:12<2091::AID-ART2>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  4. Carruthers D. M., Watts R. A., Symmons D. P., Scott D. G. Wegener's granulomatosis--increased incidence or increased recognition? Br J Rheumatol. 1996 Feb;35(2):142–145. doi: 10.1093/rheumatology/35.2.142. [DOI] [PubMed] [Google Scholar]
  5. Cotch M. F., Hoffman G. S., Yerg D. E., Kaufman G. I., Targonski P., Kaslow R. A. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996 Jan;39(1):87–92. doi: 10.1002/art.1780390112. [DOI] [PubMed] [Google Scholar]
  6. Cuadrado M. J., D'Cruz D., Lloyd M., Mujic F., Khamashta M. A., Hughes G. R. Allergic disorders in systemic vasculitis: a case-controlled study. Br J Rheumatol. 1994 Aug;33(8):749–753. doi: 10.1093/rheumatology/33.8.749. [DOI] [PubMed] [Google Scholar]
  7. Dolman K. M., Gans R. O., Vervaat T. J., Zevenbergen G., Maingay D., Nikkels R. E., Donker A. J., von dem Borne A. E., Goldschmeding R. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993 Sep 11;342(8872):651–652. doi: 10.1016/0140-6736(93)91761-a. [DOI] [PubMed] [Google Scholar]
  8. Duhaut P., Bosshard S., Calvet A., Pinede L., Demolombe-Rague S., Dumontet C., Loire R., Seydoux D., Ninet J., Pasquier J. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. J Rheumatol. 1999 Feb;26(2):361–369. [PubMed] [Google Scholar]
  9. Duna G. F., Cotch M. F., Galperin C., Hoffman D. B., Hoffman G. S. Wegener's granulomatosis: role of environmental exposures. Clin Exp Rheumatol. 1998 Nov-Dec;16(6):669–674. [PubMed] [Google Scholar]
  10. Elling P., Olsson A. T., Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol. 1996 Jan;23(1):112–119. [PubMed] [Google Scholar]
  11. Falk R. J., Hogan S., Carey T. S., Jennette J. C. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med. 1990 Nov 1;113(9):656–663. doi: 10.7326/0003-4819-113-9-656. [DOI] [PubMed] [Google Scholar]
  12. González-Gay M. A., García-Porrúa C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999 Sep;78(5):292–308. doi: 10.1097/00005792-199909000-00002. [DOI] [PubMed] [Google Scholar]
  13. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999 Jan;78(1):26–37. doi: 10.1097/00005792-199901000-00003. [DOI] [PubMed] [Google Scholar]
  14. Guillevin L., Lhote F., Amouroux J., Gherardi R., Callard P., Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol. 1996 Oct;35(10):958–964. doi: 10.1093/rheumatology/35.10.958. [DOI] [PubMed] [Google Scholar]
  15. Guillevin L., Lhote F., Leon A., Fauvelle F., Vivitski L., Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol. 1993 Feb;20(2):289–298. [PubMed] [Google Scholar]
  16. Haugeberg G., Bie R., Bendvold A., Larsen A. S., Johnsen V. Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol. 1998;17(5):364–368. doi: 10.1007/BF01450893. [DOI] [PubMed] [Google Scholar]
  17. Hunder G. G., Arend W. P., Bloch D. A., Calabrese L. H., Fauci A. S., Fries J. F., Leavitt R. Y., Lie J. T., Lightfoot R. W., Jr, Masi A. T. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990 Aug;33(8):1065–1067. doi: 10.1002/art.1780330802. [DOI] [PubMed] [Google Scholar]
  18. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187–192. doi: 10.1002/art.1780370206. [DOI] [PubMed] [Google Scholar]
  19. Kelsall J. T., Chalmers A., Sherlock C. H., Tron V. A., Kelsall A. C. Microscopic polyangiitis after influenza vaccination. J Rheumatol. 1997 Jun;24(6):1198–1202. [PubMed] [Google Scholar]
  20. Le Hello C., Cohen P., Bousser M. G., Letellier P., Guillevin L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol. 1999 Jan;26(1):191–194. [PubMed] [Google Scholar]
  21. Malaviya A. N., Kumar A., Singh Y. N., Singh R. R., Dash S. C., Khare S. D., Wali J. P., Sharma S. K., Handa R., Saluja S. Wegener's granulomatosis in India: not so rare. Br J Rheumatol. 1990 Dec;29(6):499–500. doi: 10.1093/rheumatology/29.6.499. [DOI] [PubMed] [Google Scholar]
  22. McMahon B. J., Heyward W. L., Templin D. W., Clement D., Lanier A. P. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology. 1989 Jan;9(1):97–101. doi: 10.1002/hep.1840090116. [DOI] [PubMed] [Google Scholar]
  23. Mody G. M. Rheumatoid arthritis and connective tissue disorders: sub-Saharan Africa. Baillieres Clin Rheumatol. 1995 Feb;9(1):31–44. doi: 10.1016/s0950-3579(05)80141-4. [DOI] [PubMed] [Google Scholar]
  24. Nikkari S., Mertsola J., Korvenranta H., Vainionpä R., Toivanen P. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum. 1994 Nov;37(11):1707–1708. doi: 10.1002/art.1780371122. [DOI] [PubMed] [Google Scholar]
  25. Rao J. K., Allen N. B., Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med. 1998 Sep 1;129(5):345–352. doi: 10.7326/0003-4819-129-5-199809010-00001. [DOI] [PubMed] [Google Scholar]
  26. Raynauld J. P., Bloch D. A., Fries J. F. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol. 1993 Sep;20(9):1524–1526. [PubMed] [Google Scholar]
  27. Russo M. G., Waxman J., Abdoh A. A., Serebro L. H. Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum. 1995 Mar;38(3):374–380. doi: 10.1002/art.1780380312. [DOI] [PubMed] [Google Scholar]
  28. Salvarani C., Gabriel S. E., O'Fallon W. M., Hunder G. G. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995 Aug 1;123(3):192–194. doi: 10.7326/0003-4819-123-3-199508010-00006. [DOI] [PubMed] [Google Scholar]
  29. Stegeman C. A., Tervaert J. W., de Jong P. E., Kallenberg C. G. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996 Jul 4;335(1):16–20. doi: 10.1056/NEJM199607043350103. [DOI] [PubMed] [Google Scholar]
  30. Tervaert J. W., Stegeman C. A., Kallenberg C. G. Silicon exposure and vasculitis. Curr Opin Rheumatol. 1998 Jan;10(1):12–17. doi: 10.1097/00002281-199801000-00003. [DOI] [PubMed] [Google Scholar]
  31. Tidman M., Olander R., Svalander C., Danielsson D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med. 1998 Aug;244(2):133–141. doi: 10.1046/j.1365-2796.1998.00324.x. [DOI] [PubMed] [Google Scholar]
  32. Vanoli M., Gambini D., Scorza R. A case of Churg-Strauss vasculitis after hepatitis B vaccination. Ann Rheum Dis. 1998 Apr;57(4):256–257. doi: 10.1136/ard.57.4.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wechsler M. E., Garpestad E., Flier S. R., Kocher O., Weiland D. A., Polito A. J., Klinek M. M., Bigby T. D., Wong G. A., Helmers R. A. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA. 1998 Feb 11;279(6):455–457. doi: 10.1001/jama.279.6.455. [DOI] [PubMed] [Google Scholar]
  34. el-Reshaid K., Kapoor M. M., el-Reshaid W., Madda J. P., Varro J. The spectrum of renal disease associated with microscopic polyangiitis and classic polyarteritis nodosa in Kuwait. Nephrol Dial Transplant. 1997 Sep;12(9):1874–1882. doi: 10.1093/ndt/12.9.1874. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES